Continuous Monitoring of the Lungs Ventilation Dynamics During Mechanical Ventilation
1 other identifier
observational
15
1 country
1
Brief Summary
Background: Patients that suffer from respiratory failure and need mechanical ventilation are at risk of further deterioration due to complications induced by progression of lung disease or the mechanical ventilation. The complications usually develop in a progressive manner, but are currently detected relatively late, when there is already severe and life threatening deterioration in patient oxygenation and sometimes irreversible damages. Objective:To measure chest wall dynamics, derived from sensors placed on the chest and abdomen. Methods: The system comprises of patches attached to the chest wall and upper abdomen that include mechanical sensors that measure the mechanics of lung inflation and deflation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 19, 2008
CompletedFirst Posted
Study publicly available on registry
June 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedMarch 29, 2022
March 1, 2022
1.2 years
June 19, 2008
March 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A data-bank of measured changes in lung dynamics at various clinical settings acquired by the chest sensors.
Secondary Outcomes (1)
Detection of changes in lung ventilation by the novel system. Feasibility study. Comparison of the detection made by the novel system to the conventional monitoring methods in use.
Study Arms (1)
1
Premature and term newborn infants (male/female)
Eligibility Criteria
Babies receiving respiratory support, born at 26 weeks and over \& birth weight 700 grams.
You may qualify if:
- Babies receiving respiratory support
You may not qualify if:
- Parental refusal to be included in the study
- Premature babies under 700 grams birth weight
- Prematurity below 26 weeks gestation
- Severe edematous babies (Hydrops fetalis)
- Severe Hypoxic Ischemic Encephalopathy, initial brain injury or severe intracranial bleeding or major congenital anomalies
- Skin reactions to the adhesive patches
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carmel Medical Centerlead
- Technion, Israel Institute of Technologycollaborator
Study Sites (1)
Department of Neonatology, Carmel Medical Center
Haifa, 32985, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dan Waisman, MD
Department of Neonatology Carmel Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Directon Newborn Unit
Study Record Dates
First Submitted
June 19, 2008
First Posted
June 20, 2008
Study Start
December 1, 2007
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
March 29, 2022
Record last verified: 2022-03